These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19403987)

  • 21. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
    Rau JC; Deans C; Hoffman MR; Thomas DB; Malcom GT; Zieske AW; Strong JP; Koch GG; Church FC
    Exp Mol Pathol; 2009 Dec; 87(3):178-83. PubMed ID: 19747479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and risk factors of PAD among patients with elevated ABI.
    Suominen V; Rantanen T; Venermo M; Saarinen J; Salenius J
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):709-14. PubMed ID: 18313338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical prediction model for the presence of peripheral arterial disease--the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study.
    Bendermacher BL; Teijink JA; Willigendael EM; Bartelink ML; Peters RJ; de Bie RA; Büller HR; Boiten J; Langenberg M; Prins MH
    Vasc Med; 2007 Feb; 12(1):5-11. PubMed ID: 17451087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Savvidis S; Messow CM; Munzel T; Blankenberg S;
    Circulation; 2008 Aug; 118(9):961-7. PubMed ID: 18697822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.
    Rau JC; Mitchell JW; Fortenberry YM; Church FC
    Semin Thromb Hemost; 2011 Jun; 37(4):339-48. PubMed ID: 21805439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing.
    Polonsky TS; Taillon LA; Sheth H; Min JK; Archer SL; Ward RP
    Atherosclerosis; 2009 Dec; 207(2):440-4. PubMed ID: 19501825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin cofactor II (HCII) activity and antigen assay and their significance in thrombotic diseases].
    Dai CW; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):452-4. PubMed ID: 14575585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
    Rossi EB; Duboscq CL; Kordich LC
    Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease].
    Darius H; Trampisch HJ; Pittrow D; Allenberg JR; Haberl RL; Mahn M; Tepohl HG; Burghaus I; Diehm C
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2317-22. PubMed ID: 18958826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Feb; 60(2):255-7. PubMed ID: 15814871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study.
    Moussa ID; Jaff MR; Mehran R; Gray W; Dangas G; Lazic Z; Moses JW
    Catheter Cardiovasc Interv; 2009 May; 73(6):719-24. PubMed ID: 19213068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
    Bianchi C; Penno G; Pancani F; Civitelli A; Piaggesi A; Caricato F; Pellegrini G; Del Prato S; Miccoli R
    Diabetes Res Clin Pract; 2007 Nov; 78(2):246-53. PubMed ID: 17498833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women.
    Mangiafico RA; Russo E; Riccobene S; Pennisi P; Mangiafico M; D'Amico F; Fiore CE
    J Bone Miner Metab; 2006; 24(2):125-31. PubMed ID: 16502119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Arteriomobil Project for peripheral arterial disease.
    Pfeiffer M; Bock E; Hohenberger T; Kröger K;
    Vasa; 2008 Nov; 37(4):345-52. PubMed ID: 19003745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II.
    Porter JB; Young L; Mackie IJ; Marshall L; Machin SJ
    Br J Haematol; 1993 Mar; 83(3):459-65. PubMed ID: 8485052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.